Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
There is a lot to like about The Chemours Company, but there is one issue that should give investors pause.
While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand, strong execution and its cost-reduction and pricing actions.